ID   TRPV4_RAT               Reviewed;         871 AA.
AC   Q9ERZ8;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   24-JUL-2024, entry version 161.
DE   RecName: Full=Transient receptor potential cation channel subfamily V member 4;
DE            Short=TrpV4;
DE   AltName: Full=Osm-9-like TRP channel 4;
DE            Short=OTRPC4;
DE   AltName: Full=Vanilloid receptor-related osmotically-activated channel {ECO:0000303|PubMed:11081638};
DE            Short=VR-OAC {ECO:0000303|PubMed:11081638};
GN   Name=Trpv4; Synonyms=Vroac;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TRANSPORTER ACTIVITY, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Kidney;
RX   PubMed=11081638; DOI=10.1016/s0092-8674(00)00143-4;
RA   Liedtke W.B., Choe Y., Marti-Renom M.A., Bell A.M., Denis C.S., Sali A.,
RA   Hudspeth A.J., Friedman J.M., Heller S.;
RT   "Vanilloid receptor-related osmotically activated channel (VR-OAC), a
RT   candidate vertebrate osmoreceptor.";
RL   Cell 103:525-535(2000).
RN   [2]
RP   INTERACTION WITH PACSIN1; PACSIN2 AND PACSIN3.
RX   PubMed=16627472; DOI=10.1074/jbc.m602452200;
RA   Cuajungco M.P., Grimm C., Oshima K., D'hoedt D., Nilius B.,
RA   Mensenkamp A.R., Bindels R.J., Plomann M., Heller S.;
RT   "PACSINs bind to the TRPV4 cation channel. PACSIN 3 modulates the
RT   subcellular localization of TRPV4.";
RL   J. Biol. Chem. 281:18753-18762(2006).
CC   -!- FUNCTION: Non-selective calcium permeant cation channel involved in
CC       osmotic sensitivity and mechanosensitivity (PubMed:11081638).
CC       Activation by exposure to hypotonicity within the physiological range
CC       exhibits an outward rectification (PubMed:11081638). Also activated by
CC       heat, low pH, citrate and phorbol esters (By similarity). Increase of
CC       intracellular Ca(2+) potentiates currents (By similarity). Channel
CC       activity seems to be regulated by a calmodulin-dependent mechanism with
CC       a negative feedback mechanism (By similarity). Acts as a regulator of
CC       intracellular Ca(2+) in synoviocytes (By similarity). Plays an
CC       obligatory role as a molecular component in the nonselective cation
CC       channel activation induced by 4-alpha-phorbol 12,13-didecanoate and
CC       hypotonic stimulation in synoviocytes and also regulates production of
CC       IL-8 (By similarity). Together with PKD2, forms mechano- and
CC       thermosensitive channels in cilium (By similarity). Promotes cell-cell
CC       junction formation in skin keratinocytes and plays an important role in
CC       the formation and/or maintenance of functional intercellular barriers
CC       (By similarity). Negatively regulates expression of PPARGC1A, UCP1,
CC       oxidative metabolism and respiration in adipocytes (By similarity).
CC       Regulates expression of chemokines and cytokines related to pro-
CC       inflammatory pathway in adipocytes (By similarity). Together with AQP5,
CC       controls regulatory volume decrease in salivary epithelial cells (By
CC       similarity). Required for normal development and maintenance of bone
CC       and cartilage (By similarity). In its inactive state, may sequester
CC       DDX3X at the plasma membrane. When activated, the interaction between
CC       both proteins is affected and DDX3X relocalizes to the nucleus (By
CC       similarity). In neurons of the central nervous system, could play a
CC       role in triggering voluntary water intake in response to increased
CC       sodium concentration in body fluid (By similarity).
CC       {ECO:0000250|UniProtKB:Q9EPK8, ECO:0000250|UniProtKB:Q9HBA0,
CC       ECO:0000269|PubMed:11081638}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Ca(2+)(in) = Ca(2+)(out); Xref=Rhea:RHEA:29671,
CC         ChEBI:CHEBI:29108; Evidence={ECO:0000269|PubMed:11081638};
CC   -!- SUBUNIT: Homotetramer. Interacts with calmodulin (By similarity).
CC       Interacts with MAP7 and Src family Tyr protein kinases LYN, SRC, FYN,
CC       HCK, LCK and YES (By similarity). Interacts with CTNNB1 (By
CC       similarity). The TRPV4 and CTNNB1 complex can interact with CDH1 (By
CC       similarity). Part of a complex containing MLC1, AQP4, HEPACAM and
CC       ATP1B1 (By similarity). Interacts with PACSIN1, PACSIN2 and PACSIN3
CC       (via SH3 domain) (PubMed:16627472). Interacts with ITPR3 (By
CC       similarity). Interacts with AQP5; the interaction is probably indirect
CC       and regulates TRPV4 activation by hypotonicity (By similarity).
CC       Interacts with ANO1 (By similarity). Interacts (via C-terminus) with
CC       PKD2 (via C-terminus) (By similarity). Interacts with DDX3X; this
CC       interaction is decreased when the channel is activated (By similarity).
CC       {ECO:0000250|UniProtKB:Q9EPK8, ECO:0000250|UniProtKB:Q9HBA0,
CC       ECO:0000269|PubMed:16627472}.
CC   -!- INTERACTION:
CC       Q9ERZ8; P47863: Aqp4; NbExp=4; IntAct=EBI-10095418, EBI-15907593;
CC       Q9ERZ8; P47863-1: Aqp4; NbExp=2; IntAct=EBI-10095418, EBI-15907676;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:Q9HBA0}.
CC       Apical cell membrane {ECO:0000305|PubMed:11081638}; Multi-pass membrane
CC       protein {ECO:0000250|UniProtKB:Q9HBA0}. Cell junction, adherens
CC       junction {ECO:0000250|UniProtKB:Q9EPK8}. Cell projection, cilium
CC       {ECO:0000250|UniProtKB:Q9HBA0}. Note=Assembly of the putative
CC       homotetramer occurs primarily in the endoplasmic reticulum.
CC       Localization to the cell membrane is inhibited by WNK kinases (WNK1,
CC       WNK2, WNK3 or WNK4) in a kinase-independent mechanism.
CC       {ECO:0000250|UniProtKB:Q9HBA0}.
CC   -!- TISSUE SPECIFICITY: Expressed lung, spleen, kidney, testis, fat, and at
CC       very low levels in trigeminal ganglia. {ECO:0000269|PubMed:11081638}.
CC   -!- DOMAIN: The ANK repeat region mediates interaction with Ca(2+)-
CC       calmodulin and ATP binding. The ANK repeat region mediates interaction
CC       with phosphatidylinositol-4,5-bisphosphate and related
CC       phosphatidylinositides. {ECO:0000250|UniProtKB:A0A1D5PXA5}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q9EPK8}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family. TrpV
CC       subfamily. TRPV4 sub-subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF263521; AAG28027.1; -; mRNA.
DR   RefSeq; NP_076460.1; NM_023970.1.
DR   RefSeq; XP_006249528.1; XM_006249466.2.
DR   AlphaFoldDB; Q9ERZ8; -.
DR   EMDB; EMD-23477; -.
DR   SMR; Q9ERZ8; -.
DR   BioGRID; 249353; 2.
DR   DIP; DIP-59600N; -.
DR   IntAct; Q9ERZ8; 3.
DR   STRING; 10116.ENSRNOP00000001586; -.
DR   BindingDB; Q9ERZ8; -.
DR   ChEMBL; CHEMBL2775; -.
DR   DrugCentral; Q9ERZ8; -.
DR   GuidetoPHARMACOLOGY; 510; -.
DR   TCDB; 1.A.4.2.5; the transient receptor potential ca2+/cation channel (trp-cc) family.
DR   iPTMnet; Q9ERZ8; -.
DR   PhosphoSitePlus; Q9ERZ8; -.
DR   PaxDb; 10116-ENSRNOP00000001586; -.
DR   Ensembl; ENSRNOT00000001586.3; ENSRNOP00000001586.1; ENSRNOG00000001195.3.
DR   Ensembl; ENSRNOT00055003153; ENSRNOP00055002364; ENSRNOG00055001978.
DR   Ensembl; ENSRNOT00060007995; ENSRNOP00060005981; ENSRNOG00060004776.
DR   Ensembl; ENSRNOT00065011080; ENSRNOP00065008117; ENSRNOG00065007095.
DR   GeneID; 66026; -.
DR   KEGG; rno:66026; -.
DR   UCSC; RGD:69337; rat.
DR   AGR; RGD:69337; -.
DR   CTD; 59341; -.
DR   RGD; 69337; Trpv4.
DR   eggNOG; KOG3676; Eukaryota.
DR   GeneTree; ENSGT00940000158615; -.
DR   HOGENOM; CLU_012795_1_0_1; -.
DR   InParanoid; Q9ERZ8; -.
DR   OMA; KVCNQDQ; -.
DR   OrthoDB; 1003028at2759; -.
DR   PhylomeDB; Q9ERZ8; -.
DR   TreeFam; TF314711; -.
DR   Reactome; R-RNO-3295583; TRP channels.
DR   PRO; PR:Q9ERZ8; -.
DR   Proteomes; UP000002494; Chromosome 12.
DR   Bgee; ENSRNOG00000001195; Expressed in adult mammalian kidney and 15 other cell types or tissues.
DR   GO; GO:0005912; C:adherens junction; ISS:UniProtKB.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0009986; C:cell surface; IDA:RGD.
DR   GO; GO:0005929; C:cilium; ISO:RGD.
DR   GO; GO:0030864; C:cortical actin cytoskeleton; IDA:BHF-UCL.
DR   GO; GO:0030175; C:filopodium; IDA:BHF-UCL.
DR   GO; GO:0005925; C:focal adhesion; IDA:BHF-UCL.
DR   GO; GO:0030426; C:growth cone; IDA:BHF-UCL.
DR   GO; GO:0030027; C:lamellipodium; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0032587; C:ruffle membrane; IDA:BHF-UCL.
DR   GO; GO:0003779; F:actin binding; IDA:BHF-UCL.
DR   GO; GO:0051015; F:actin filament binding; IDA:BHF-UCL.
DR   GO; GO:0043014; F:alpha-tubulin binding; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0048487; F:beta-tubulin binding; IDA:BHF-UCL.
DR   GO; GO:0005262; F:calcium channel activity; IDA:BHF-UCL.
DR   GO; GO:0005516; F:calmodulin binding; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0008289; F:lipid binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008017; F:microtubule binding; IDA:BHF-UCL.
DR   GO; GO:0005261; F:monoatomic cation channel activity; IDA:RGD.
DR   GO; GO:0005034; F:osmosensor activity; ISO:RGD.
DR   GO; GO:0019901; F:protein kinase binding; ISO:RGD.
DR   GO; GO:0005080; F:protein kinase C binding; IDA:BHF-UCL.
DR   GO; GO:0042169; F:SH2 domain binding; ISO:RGD.
DR   GO; GO:0015275; F:stretch-activated, monoatomic cation-selective, calcium channel activity; ISO:RGD.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IDA:BHF-UCL.
DR   GO; GO:0007015; P:actin filament organization; IDA:BHF-UCL.
DR   GO; GO:0097497; P:blood vessel endothelial cell delamination; ISO:RGD.
DR   GO; GO:0070509; P:calcium ion import; IDA:BHF-UCL.
DR   GO; GO:1902656; P:calcium ion import into cytosol; ISS:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0060351; P:cartilage development involved in endochondral bone morphogenesis; ISO:RGD.
DR   GO; GO:0007043; P:cell-cell junction assembly; ISS:UniProtKB.
DR   GO; GO:0071476; P:cellular hypotonic response; ISO:RGD.
DR   GO; GO:0071477; P:cellular hypotonic salinity response; ISO:RGD.
DR   GO; GO:0034605; P:cellular response to heat; ISS:UniProtKB.
DR   GO; GO:0071470; P:cellular response to osmotic stress; ISS:UniProtKB.
DR   GO; GO:0043622; P:cortical microtubule organization; IDA:BHF-UCL.
DR   GO; GO:0002024; P:diet induced thermogenesis; ISO:RGD.
DR   GO; GO:0097009; P:energy homeostasis; ISO:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0042538; P:hyperosmotic salinity response; ISO:RGD.
DR   GO; GO:0006971; P:hypotonic response; IDA:RGD.
DR   GO; GO:0006874; P:intracellular calcium ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0046785; P:microtubule polymerization; IDA:BHF-UCL.
DR   GO; GO:0050891; P:multicellular organismal-level water homeostasis; IMP:UniProtKB.
DR   GO; GO:1903444; P:negative regulation of brown fat cell differentiation; ISO:RGD.
DR   GO; GO:0010977; P:negative regulation of neuron projection development; IDA:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0007231; P:osmosensory signaling pathway; ISO:RGD.
DR   GO; GO:0071651; P:positive regulation of chemokine (C-C motif) ligand 5 production; ISO:RGD.
DR   GO; GO:2000340; P:positive regulation of chemokine (C-X-C motif) ligand 1 production; ISO:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IDA:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; ISO:RGD.
DR   GO; GO:0046330; P:positive regulation of JNK cascade; ISO:RGD.
DR   GO; GO:0010759; P:positive regulation of macrophage chemotaxis; ISO:RGD.
DR   GO; GO:0071642; P:positive regulation of macrophage inflammatory protein 1 alpha production; ISO:RGD.
DR   GO; GO:0031117; P:positive regulation of microtubule depolymerization; IDA:BHF-UCL.
DR   GO; GO:0071639; P:positive regulation of monocyte chemotactic protein-1 production; ISO:RGD.
DR   GO; GO:0045989; P:positive regulation of striated muscle contraction; IMP:RGD.
DR   GO; GO:0043117; P:positive regulation of vascular permeability; IMP:UniProtKB.
DR   GO; GO:1903715; P:regulation of aerobic respiration; ISO:RGD.
DR   GO; GO:0047484; P:regulation of response to osmotic stress; ISO:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0032868; P:response to insulin; ISO:RGD.
DR   GO; GO:0006970; P:response to osmotic stress; ISO:RGD.
DR   GO; GO:0030103; P:vasopressin secretion; ISO:RGD.
DR   CDD; cd22195; TRPV4; 1.
DR   Gene3D; 1.10.287.70; -; 1.
DR   Gene3D; 1.25.40.20; Ankyrin repeat-containing domain; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR024862; TRPV.
DR   InterPro; IPR008347; TrpV1-4.
DR   InterPro; IPR008348; TrpV4.
DR   NCBIfam; TIGR00870; trp; 1.
DR   PANTHER; PTHR10582:SF4; TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 4; 1.
DR   PANTHER; PTHR10582; TRANSIENT RECEPTOR POTENTIAL ION CHANNEL PROTEIN; 1.
DR   Pfam; PF00023; Ank; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01768; TRPVRECEPTOR.
DR   PRINTS; PR01769; VRL2RECEPTOR.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; Ankyrin repeat; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; ATP-binding; Calcium; Calcium channel; Calcium transport;
KW   Calmodulin-binding; Cell junction; Cell membrane; Cell projection; Cilium;
KW   Glycoprotein; Ion channel; Ion transport; Lipid-binding; Membrane;
KW   Metal-binding; Nucleotide-binding; Phosphoprotein; Reference proteome;
KW   Repeat; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..871
FT                   /note="Transient receptor potential cation channel
FT                   subfamily V member 4"
FT                   /id="PRO_0000215349"
FT   TOPO_DOM        1..469
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TRANSMEM        470..490
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TOPO_DOM        491..507
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TRANSMEM        508..534
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TOPO_DOM        535..547
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TRANSMEM        548..568
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TOPO_DOM        569..572
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TRANSMEM        573..593
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TOPO_DOM        594..608
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TRANSMEM        609..636
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TOPO_DOM        637..665
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   INTRAMEM        666..685
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TOPO_DOM        686..693
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TRANSMEM        694..722
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TOPO_DOM        723..871
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   REPEAT          237..266
FT                   /note="ANK 1"
FT   REPEAT          284..313
FT                   /note="ANK 2"
FT   REPEAT          369..398
FT                   /note="ANK 3"
FT   REGION          1..68
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          110..143
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          812..831
FT                   /note="Interaction with calmodulin and ITPR3"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HBA0"
FT   MOTIF           679..682
FT                   /note="Selectivity filter"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   COMPBIAS        112..131
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         192
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HBA0"
FT   BINDING         197
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HBA0"
FT   BINDING         201
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HBA0"
FT   BINDING         236..239
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HBA0"
FT   BINDING         248
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9HBA0"
FT   BINDING         249..251
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-4,5-bisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58456"
FT                   /evidence="ECO:0000250|UniProtKB:A0A1D5PXA5"
FT   BINDING         296..299
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-4,5-bisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58456"
FT                   /evidence="ECO:0000250|UniProtKB:A0A1D5PXA5"
FT   BINDING         344
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol-4,5-bisphosphate)"
FT                   /ligand_id="ChEBI:CHEBI:58456"
FT                   /evidence="ECO:0000250|UniProtKB:A0A1D5PXA5"
FT   BINDING         682
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_note="ligand shared between two neighboring
FT                   subunits"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R186"
FT   MOD_RES         110
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9EPK8"
FT   MOD_RES         253
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9EPK8"
FT   MOD_RES         805
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9EPK8"
FT   MOD_RES         824
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9EPK8"
SQ   SEQUENCE   871 AA;  98010 MW;  5D50684DA08C354B CRC64;
     MADPGDGPRA APGDVAEPPG DESGTSGGEA FPLSSLANLF EGEEGSSSLS PVDASRPAGP
     GDGRPNLRMK FQGAFRKGVP NPIDLLESTL YESSVVPGPK KAPMDSLFDY GTYRHHPSDN
     KRWRRKVVEK QPQSPKAPAP QPPPILKVFN RPILFDIVSR GSTADLDGLL SYLLTHKKRL
     TDEEFREPST GKTCLPKALL NLSNGRNDTI PVLLDIAERT GNMREFINSP FRDIYYRGQT
     ALHIAIERRC KHYVELLVAQ GADVHAQARG RFFQPKDEGG YFYFGELPLS LAACTNQPHI
     VNYLTENPHK KADMRRQDSR GNTVLHALVA IADNTRENTK FVTKMYDLLL LKCSRLFPDS
     NLETVLNNDG LSPLMMAAKT GKIGVFQHII RREVTDEDTR HLSRKFKDWA YGPVYSSLYD
     LSSLDTCGEE VSVLEILVYN SKIENRHEML AVEPINELLR DKWRKFGAVS FYINVVSYLC
     AMVIFTLTAY YQPLEGTPPY PYRTTVDYLR LAGEVITLLT GVLFFFTSIK DLFMKKCPGV
     NSLFVDGSFQ LLYFIYSVLV VVSAALYLAG IEAYLAVMVF ALVLGWMNAL YFTRGLKLTG
     TYSIMIQKIL FKDLFRFLLV YLLFMIGYAS ALVTLLNPCT NMKVCNEDQS NCTVPSYPAC
     RDSETFSAFL LDLFKLTIGM GDLEMLSSAK YPVVFILLLV TYIILTFVLL LNMLIALMGE
     TVGQVSKESK HIWKLQWATT ILDIERSFPV FLRKAFRSGE MVTVGKSSDG TPDRRWCFRV
     DEVNWSHWNQ NLGIINEDPG KSEIYQYYGF SHTMGRLRRD RWSSVVPRVV ELNKNSGTDE
     VVVPLDNLGN PNCDGHQQGY APKWRAEDAP L
//
